Molecular Templates, Inc.

Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending December 31, 2019

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Learn More

Company Overview

Molecular Templates is focused on the discovery, development, and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.

Investor Contact Information

Company

Molecular Templates, Inc.
9301 Amberglen Blvd
Suite 100
Austin, TX 78729

Investor Relations

Adam Cutler
Chief Financial Officer
T: 862-204-4006
adam.cutler@mtem.com

Transfer Agent

Computershare
PO Box 358015
Pittsburgh, PA 15252
T: 781-575-3120